Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients

Human Genomics

Volumn 7, Issue 1, 2013, Pages

  Marlow, Gareth ^a   Ellett, Stephanie ^a   Ferguson, Isobel R ^a   Zhu, Shuotun ^a   Karunasinghe, Nishi ^a   Jesuthasan, Amalini C ^a   Han, Dug Yeo ^a   Fraser, Alan G ^a   Ferguson, Lynnette R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Crohn's disease; Dietary intervention; Inflammation; Transcriptomics

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; RNA; TRANSCRIPTOME;

ARTICLE; CROHN DISEASE; DIET THERAPY; DIETARY COMPLIANCE; GENE EXPRESSION; HUMAN; INTESTINE FLORA; MEDITERRANEAN DIET; MICRONUCLEUS TEST; PILOT STUDY; PROTEIN BLOOD LEVEL; TRANSCRIPTOMICS; ADULT; BLOOD; DNA DAMAGE; FEMALE; GASTROINTESTINAL TRACT; GENETICS; INFLAMMATION; INTERVENTION STUDY; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROHN DISEASE; DIET, MEDITERRANEAN; DNA DAMAGE; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERVENTION STUDIES; MALE; MICROBIOTA; MICRONUCLEUS TESTS; MIDDLE AGED; PILOT PROJECTS; RNA; TRANSCRIPTOME;

EID: 84901006573     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-7-24     Document Type: Article

References (51)

1. Ferguson LR: Potential value of nutrigenomics in Crohn's disease. Nat Rev Gastroenterol Hepatol 2012, 9(5):260-270.
2. Calder PC: Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011, 668(Suppl 1):S50-58.
3. Corfield AP, Wallace HM, Probert CS: The molecular biology of inflammatory bowel diseases. Biochem Soc Trans 2011, 39(4):1057-1060.
4. Serhan CN: The resolution of inflammation: the devil in the flask and in the details. FASEB J 2011, 25(5):1441-1448.
5. Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NH, Kooistra T, van Ommen B, Hendriks HF: An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr 2010, 91(4):1044-1059.
6. Bannenberg G, Serhan CN: Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta 2010, 1801(12):1260-1273.
7. Gentschew L, Ferguson LR: Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res 2012, 56(4):524-535.
8. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres C, Chotard V, Budai B, Law L, Levy E, Seidman EG: Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007, 102(9):2016-2025. (Pubitemid 47301536)
9. D'Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirian P, Deslandres C, Morgan K, Seidman EG, Amre DK: Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008, 14(3):367-373. (Pubitemid 351441326)
10. Issa M, Saeian K: Diet in inflammatory bowel disease. Nutr Clin Pract 2011, 26(2):151-154.
11. Brown K, DeCoffe D, Molcan E, Gibson DL: Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012, 4(8):1095-1119.
12. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104(34):13780-13785. (Pubitemid 350003397)
13. Greenblum S, Turnbaugh PJ, Borenstein E: Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A 2012, 109(2):594-599.
14. Albenberg LG, Lewis JD, Wu GD: Food and the gut microbiota in inflammatory bowel diseases: a critical connection. Curr Opin Gastroenterol 2012, 28(4):314-320.
15. Candela M, Rampelli S, Turroni S, Severgnini M, Consolandi C, De Bellis G, Masetti R, Ricci G, Pession A, Brigidi P: Unbalance of intestinal microbiota in atopic children. BMC Microbiol 2012, 12:95.
16. Hattori M, Taylor TD: The human intestinal microbiome: a new frontier of human biology. DNA Res 2009, 16(1):1-12.
17. Candela M, Biagi E, Maccaferri S, Turroni S, Brigidi P: Intestinal microbiota is a plastic factor responding to environmental changes. Trends Microbiol 2012, 20(8):385-391.
18. Candela M, Consolandi C, Severgnini M, Biagi E, Castiglioni B, Vitali B, De Bellis G, Brigidi P: High taxonomic level fingerprint of the human intestinal microbiota by Ligase Detection Reaction - Universal Array approach. BMC Microbiol 2010, 10:116.
19. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J: Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55(2):205-211. (Pubitemid 43117279)
20. Sokol H, Lay C, Seksik P, Tannock GW: Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis 2008, 14(6):858-867. (Pubitemid 351898071)
21. Rajilic-Stojanovic M, Heilig HG, Molenaar D, Kajander K, Surakka A, Smidt H, de Vos WM: Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009, 11(7):1736-1751.
22. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, Muller M, Afman LA: Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009, 90(2):415-424.
23. Esposito K, Di Palo C, Maiorino MI, Petrizzo M, Bellastella G, Siniscalchi I, Giugliano D: Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men. Cardiol Res Pract 2011, 2011:293916.
24. Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D: Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord 2011, 9(1):1-12.
25. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB: The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011, 57(11):1299-1313.
26. Sola R, Fito M, Estruch R, Salas-Salvado J, Corella D, de La Torre R, Munoz MA, Lopez-Sabater Mdel C, Martinez-Gonzalez MA, Aros F, Ruiz-Gutierrez V, Fiol M, Casals E, Wärnberg J, Buil-Cosiales P, Ros E, Konstantinidou V, Lapetra J, Serra-Majem L, Covas MI: Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial. Atherosclerosis 2011, 218(1):174-180.
27. Nanau R, Neuman M: Nutritional and probiotic supplementation in colitis models. Dig Dis Sci 2012, 57(11):2786-2810.
28. Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML, Ferguson LR: Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutat Res 2010, 690(1-2):123-138.
29. Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Marlow G, Hurley D, Lam WJ, Han DY, Ferguson LR: Foodomics to study efficacy of human dietary interventions: proof of principle study. In Nutrigenomics and Nutrigenetics in Functional Foods and Personalized Nutrition. Edited by Ferguson LR. Boca Raton, FL: CRC Press; 2013.
30. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ: C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 2010, 31(17):2087-2091.
31. Karadag F, Kirdar S, Karul AB, Ceylan E: The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 2008, 19(2):104-108.
32. Thomas P, Fenech M: Cytokinesis-block micronucleus cytome assay in lymphocytes. Methods Mol Biol 2011, 682:217-234.
33. de Graaf AA, Freidig AP, De Roos B, Jamshidi N, Heinemann M, Rullmann JA, Hall KD, Adiels M, van Ommen B: Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput Biol 2009, 5(11):e1000554.
34. Puiggros F, Sola R, Blade C, Salvado MJ, Arola L: Nutritional biomarkers and foodomic methodologies for qualitative and quantitative analysis of bioactive ingredients in dietary intervention studies. J Chromatogr A 2011, 1218(42):7399-7414.
35. Chae M, Kim K, Park S-M, Jang I-S, Seo T, Kim D-M, Kim I-C, Lee J-H, Park J: IRF-2 regulates NF-κB activity by modulating the subcellular localization of NF-κB. Biochem Biophys Res Commun 2008, 370(3):519-524.
36. Sugimoto K: Role of STAT3 in inflammatory bowel disease. World J Gastroenterol 2008, 14(33):5110-5114.
37. Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ: New insights into the role of STAT3 in IBD. Inflamm Bowel Dis 2012, 18(6):1177-1183.
38. de Mello VD, Kolehmanien M, Schwab U, Pulkkinen L, Uusitupa M: Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: what do we know so far? Mol Nutr Food Res 2012, 56(7):1160-1172.
39. Rudkowska I, Ponton A, Jacques H, Lavigne C, Holub BJ, Marette A, Vohl MC: Effects of a supplementation of n-3 polyunsaturated fatty acids with or without fish gelatin on gene expression in peripheral blood mononuclear cells in obese, insulin-resistant subjects. J Nutrigenet Nutrigenomics 2011, 4(4):192-202.
40. Rudkowska I, Raymond C, Ponton A, Jacques H, Lavigne C, Holub BJ, Marette A, Vohl MC: Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. OMICS 2011, 15(1-2):1-7.
41. Bomprezzi R, Ringner M, Kim S, Bittner ML, Khan J, Chen Y, Elkahloun A, Yu A, Bielekova B, Meltzer PS, Martin R, McFarland HF, Trent JM: Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 2003, 12(17):2191-2199. (Pubitemid 37098989)
42. Connolly PH, Caiozzo VJ, Zaldivar F, Nemet D, Larson J, Hung SP, Heck JD, Hatfield GW, Cooper DM: Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 2004, 97(4):1461-1469. (Pubitemid 39299366)
43. Dabek J, Kulach A, Wilczok T, Mazurek U, Jakubowski D, Gasior Z: Transcriptional activity of genes encoding interferon gamma (IFNgamma) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X. Inflammation 2007, 30(3-4):125-129. (Pubitemid 46985777)
44. Rokutan K, Morita K, Masuda K, Tominaga K, Shikishima M, Teshima-Kondo S, Omori T, Sekiyama A: Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response. J Med Invest 2005, 52(3-4):137-144. (Pubitemid 41602587)
45. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347(25):1999-2009.
46. Di Paolo S, Schena A, Stallone G, Grandaliano G, Soccio M, Cerullo G, Gesualdo L, Paolo Schena F: Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients. Transplantation 2002, 74(12):1710-1715. (Pubitemid 36019324)
47. Fuchs D, Piller R, Linseisen J, Daniel H, Wenzel U: The human peripheral blood mononuclear cell proteome responds to a dietary flaxseedintervention and proteins identified suggest a protective effect in atherosclerosis. Proteomics 2007, 7(18):3278-3288. (Pubitemid 47517943)
48. Theuwissen E, Plat J, Mensink RP: Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol Nutr Food Res 2009, 53(3):370-376.
49. Shelby MD: A report on guidelines for mutagenicity testing. "Report of the UKEMS Sub-Committee on Guidelines for Mutagenicity Testing. Part 1: Basic Test Battery; Minimal Criteria; Professional Standards; Interpretation; Selection of Supplementary Assays," Brian J. Dean (ed). London: UKEMS, 1983. Environ Mutagen 1983, 5(6):941-943.
50. Heddle JA, Lue CB, Saunders EF, Benz RD: Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method. Cancer Res 1978, 38(9):2983-2988. (Pubitemid 9001403)
51. Fenech M: The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993, 285(1):35-44. (Pubitemid 23029552)